Inmune Bio, Inc.
Ebstrocel™
RDEB
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on Ebstrocel™ for RDEB is expected Date TBD.
Primary source
· SEC 8-K
verified 13h ago
“The Company also intends to use the MHRA feedback to inform future interactions with the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) with additional filings planned in late 2026 or early 2027, subject to ”